Microbiota and Cancer Immunity (K2)
March 17-20, 2024
| Humanities/Social Sciences Building of Academia Sinica, Taipei, Taiwan
Giorgio Trinchieri, Jenny P.Y. Ting, Hsing-Jien Kung and Shie-Liang Hsieh
Scholarship Deadline: Dec. 26, 2023 | Abstract Deadline: Dec. 26, 2023 | Early Registration Deadline: Jan. 17, 2024
| 4:00–8:00 PM |
Arrival and Registration |
The Lounge, Courtyard Marriott |
| 6:00–8:00 PM |
Welcome Mixer |
The Lounge, Courtyard Marriott |
| 8:00–9:00 AM |
Breakfast |
Individual Hotel |
| 8:30–9:00 AM |
Poster Setup |
South Wing |
| 9:00–10:00 AM |
Welcome and Keynote Address |
International Conference Hall |
| 9:00–10:00 AM |
Keynote Address |
International Conference Hall |
| |
Arlene H. Sharpe, Harvard Medical School
The Multi-Faceted Functions of the PD-1 Pathway |
|
| 9:00–7:00 PM |
Poster Viewing |
South Wing |
| 10:00–12:15 PM |
Microbiota and Immunity |
International Conference Hall |
| |
Giorgio Trinchieri, NCI, National Institutes of Health
Microbiota and Cancer Immunotherapy |
|
| |
Kenya Honda, Keio University School of Medicine
Understanding Gut Microbiota and Its Possible Role in Preventing Cancer |
|
| |
Cheng-Yuan Kao, Amgen
Host Genes Shaping Gut Microbiota, Barrier Functions and Immune Responses |
|
| |
Sergei Grivennikov, Cedars-Sinai Medical Center
Short Talk: Short Talk: Microbiota Induced Cytokines Control Inflammation, Anti-Tumor Immunity and Colorectal Cancer Metastasis |
|
| |
Kylynda C Bauer †, National Institutes of Health - National Cancer Institute
Short Talk: Short Talk: Gut Microbiome-Brain Arc Shapes Liver Anti-Tumor Immunity |
|
| 10:30–10:50 AM |
Coffee Break |
Foyer |
| 12:15–1:15 PM |
Lunch |
Back Corridor |
| 12:30–2:30 PM |
Poster Session 1 |
South Wing |
| 2:30–4:30 PM |
Panel: Effects of Race and Ethnicity on Microbiome: Impacts on Cancer Health Disparities |
International Conference Hall |
| 4:30–5:00 PM |
Coffee Available |
Foyer |
| 5:00–7:00 PM |
Microbiota and Cancer |
International Conference Hall |
| |
Sin-Hyeog Im, POSTECH
Modulation of Iron Sequestration by Commensal Microbes to Augment Tumor Immunity |
|
| |
Wen-Ching Wang, National Tsing Hua University
Strategic Evasion of Host Defense by Helicobacter pylori |
|
| |
Bertalan Takacs, Biological Research Centre, Szeged
Short Talk: Short Talk: Comparative Analysis of the Microbial Composition of Different Tumor Tissues |
|
| |
Polina Turbina, University of Luxembourg
Short Talk: Short Talk: A Personalised Cancer-on-Chip Model for the Study of Gut Microbiota in Colorectal Cancer Initiation and Progression |
|
| |
Jonas Schluter, NYU Langone Health
Short Talk: Short Talk: Cross-kingdom Ecosystem Dynamics in the Gut Influence Immunotherapy Outcomes and May Be Targeted Therapeutically |
|
| 7:00–8:00 PM |
On Own for Dinner |
|
| 8:00–9:00 AM |
Breakfast |
Individual Hotel |
| 8:30–9:00 AM |
Poster Setup |
South Wing |
| 9:00–12:00 PM |
Microbiota and Cancer Therapy |
International Conference Hall |
| |
Marlies Meisel, University of Pittsburgh
Exercise-Induced Microbiota Changes Enhance Cancer Immunotherapy Efficacy in Melanoma |
|
| |
Yardena Samuels, Weizmann Institute of Science
Towards Deciphering the Neo-Antigenic and Microbial Landscapes in Melanoma |
|
| |
Marcel van den Brink, City of Hope
The Role of the Intestinal Microbiome in Cancer Immunotherapy |
|
| |
Laurence Zitvogel, Institut Gustave Roussy
Microbiota in Anti-Lung Cancer Immunotherapy |
|
| |
Ashray Gunjur, Wellcome Sanger Institute
Short Talk: Short Talk: A Pan-Cancer Gut Microbial Response Signature for Combination Immune Checkpoint Blockade Using Genome-Resolved Metagenomics |
|
| |
Luigi Nezi, European Institute of Oncology
Short Talk: Short Talk: Stability of the Gut Microbiota During Anti-pd1 Immunotherapy Defines Complete Response in Melanoma Patients |
|
| 9:00–7:00 PM |
Poster Viewing |
South Wing |
| 10:00–10:20 AM |
Coffee Break |
Foyer |
| 12:00–1:00 PM |
Lunch |
Back Corridor |
| 12:30–2:30 PM |
Poster Session 2 |
South Wing |
| 3:00–4:30 PM |
Career Roundtable |
Back Corridor |
| |
Cheng-Yuan Kao, Amgen
Principal Scientist - Inflammation Therapeutic Area |
|
| |
Florencia McAllister, MD Anderson Cancer Center
Physician Scientist/Associate Professor |
|
| |
Wanjun Chen, NIDCR, National Institutes of Health
Senior Investigator |
|
| 4:30–5:00 PM |
Coffee Available |
Foyer |
| 5:00–7:00 PM |
Innate Resistance |
International Conference Hall |
| |
Andreas Diefenbach, Charité – Universitätsmedizin Berlin
IL-22 and Genotoxic Stress Response of Epithelial Stem Cells |
|
| |
Florencia McAllister, MD Anderson Cancer Center
Talk Title to be Announced |
|
| |
Kuo-I Lin, Academia Sinica
Signaling and Molecular Pathways Contributing to B Cell Chronic Lymphocytic Leukemia Progression and the Survival of Multiple Myeloma |
|
| |
Marco Colonna, Washington University School of Medicine
Pre-Recorded: TREM 2 in Cancer |
|
| 7:00–8:00 PM |
On Own for Dinner |
|
Wednesday, March 20, 2024
| 8:00–9:00 AM |
Breakfast |
Individual Hotel |
| 9:00–12:00 PM |
Innate and Immune Cells in the Tumor Microenvironment |
International Conference Hall |
| |
Yi-Ching Wang, National Cheng Kung University
Post-Translational Modifications of PD-1 in Regulating T cell Functionality |
|
| |
Chen Dong, Tsinghua University
Pre-Recorded: Tumor Infiltrating Myeloid Cells and Impact on Checkpoint Inhibition |
|
| |
Mien-Chie Hung, China Medical University
Marker-Guided Effective Therapy (Mget) and Tumor Microenvironment |
|
| |
Ping-Chih Ho, Ludwig Institute for Cancer Research
Short Talk: Short Talk: Heme-Mediated Reprogramming on Guiding CD8+ T Cell Exhaustion in Response to Mitochondrial Dysfunction |
|
| |
Jian-Da Lin, National Taiwan University
Short Talk: Short Talk: Elucidating the Possible Associations Between Gut Microbiota and Immunity in Pancreatic Cancer with Single-Cell Multi-Omics Technology |
|
| |
Brendan Jenkins, The University of Adelaide
Short Talk: Short Talk: The Driver Role of Innate Immune Pattern Recognition Receptors in Pancreatic Cancer |
|
| 10:00–10:20 AM |
Coffee Break |
Foyer |
| 12:00–1:00 PM |
Lunch |
Back Corridor |
| 2:30–4:30 PM |
Workshop |
International Conference Hall |
| |
Erik Thiele Orberg, University Clinic Rechts der Isar, Technical University Munich
Bacteria and Bacteriophage Consortia are Associated with Protective Intestinal Microbial Metabolites in Patients Receiving Stem Cell Transplantation |
|
| |
Kuan-lin Huang, Icahn School of Medicine at Mount Sinai
AI-Guided Prediction of Personalized Immunotherapy Outcomes |
|
| |
Jennifer Pak Yan Ho, Columbia University
Colon-Derived Ketone Bodies Modulate Metabolic Inflammation and Bacteria-Mediated Pro-Tumor Immunity |
|
| |
Xiaojing Ma, Weill Cornell Medical College
Targeting a Novel E3 Ubiquitin Ligase for Cancer Immunotherapy |
|
| |
Hung-Chia Hsieh, National Cheng Kung University
Deubiquitinase USP24 Suppresses T Cell Anti-Tumor Activity via Enhancement of PD-1 Protein Stability |
|
| |
Ching-Yu Lin, Taipei Medical University
Metabolic Modulation of Drug Resistance and Tumor Microenvironment in Prostate Cancer |
|
| 4:30–5:00 PM |
Coffee Available |
Foyer |
| 5:00–6:00 PM |
Tumor Immunity and Immunitherapeutics |
International Conference Hall |
| |
* Yi-Ching Wang, National Cheng Kung University
Session Chair |
|
| |
Muh-Hwa Yang, National Yang Ming Chiao Tung University
Tumor-Associated Macrophages: Unveiling the Pathogenic Role and Unlocking the Therapeutic Potential |
|
| |
Robert Jenq, University of Texas MD Anderson Cancer Center
Short Talk: Short Talk: Bacteroides Ovatus Reduces Intestinal Graft-Versus-Host Disease Severity |
|
| |
Kai Trepka, University of California San Francisco
Short Talk: Short Talk: Oral Fluoropyrimidine Treatment Rapidly Alters the Gut Microbiota of Colorectal Cancer Patients, Selecting for Drug-Metabolizing Microbes |
|
| 6:00–6:45 PM |
Closing Keynote Address |
International Conference Hall |
| |
Jenny P.Y. Ting, University of North Carolina at Chapel Hill
The Impact of Innate Immune Receptor on Immunity, Cancer and the Microbiota |
|
| 7:00–8:00 PM |
On Own for Dinner |
|
